← European Medicine Shortage Tracker · all medicines

Temozolomid shortage — availability across Europe

Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.

MEDICALLY REVIEWED
Dr. Chrysoula I. Liakou MD, PhD
Internal Medicine Specialist
Cancer Immunology Researcher
Reviewed 30 July 2026 · next review due 30 January 2027

Temozolomid currently has availability issues reported in 2 European registers: Greece, Sweden.

Shortage  ATC L01AX03 · also listed as: TEMOZOLOMID · TEMOZOLOMIDE · data refreshed 14 September 2026

Key facts

As of 14 September 2026, 2 of the 9 tracked registers list current availability issues for Temozolomid, covering 5 affected product presentations. The longest-running open report was filed in Greece on 2026-04-20 and has now been open for about 5 months. Where agencies state a cause, delivery delays lead with 3 of the 3 stated-cause reports. The furthest expected-resolution date currently on file is 2026-09-14; the earliest is 2026-09-14. Notably, 4 reports have already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. Momentum is current, not historical: 2 of the open reports were filed within the last 90 days. Registers in Greece, Sweden indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Temozolomid is coded L01AX03 — a medicine acting on antineoplastic and immunomodulating agents — so clinically related products appear under “Related medicines” below.

WhereStatus & productsSinceExpected end Reason / alternativesSource
🇦🇹 AustriaResolved
Temodal 180 mg Hartkapseln
2026-01-27register ↗
🇬🇷 GreeceLimited availability
RIDOCA CAPS 140MG/CAP BTx20
+ 2 more products
RIDOCA CAPS 20MG/CAP BTx5
RIDOCA CAPS 5MG/CAP BTx5
2026-04-202026-07-31ΕΝΟΡΑΣΙΣ ΑΕ Καθυστέρηση παράδοσης περιεκτικότητας. Εναλλακτικά το ίδιο
Alternatives: Εναλλακτικά άλλα σκευάσματα της ίδιας δραστικής, μορφής και
register ↗
🇸🇪 SwedenShortage
Temozolomid STADA 250 mg Kapsel, hård
+ 1 more products
Temozolomide Accord 20 mg Kapsel, hård
2026-06-302026-09-14
Alternatives: Alternative(s) available — see the national register.
register ↗

New register reports per month

2026-01: 12026-02: 02026-03: 02026-04: 12026-05: 02026-06: 32026-07: 12026-012026-07

Full report history (6 register entries)

Every individual register entry for Temozolomid in the tracked sources, newest first — including resolved and discontinued reports.

Reg.ProductStatusReportedExpected endStated reason
🇸🇪 SETemozolomide Accord 20 mg Kapsel, hårdShortage2026-07-092026-08-28
🇸🇪 SETemozolomid STADA 250 mg Kapsel, hårdShortage2026-06-302026-09-14
🇬🇷 GRRIDOCA CAPS 5MG/CAP BTx5Limited availability2026-06-102026-07-31ΕΝΟΡΑΣΙΣ ΑΕ Καθυστέρηση παράδοσης περιεκτικότητας
🇬🇷 GRRIDOCA CAPS 140MG/CAP BTx20Limited availability2026-06-022026-07-25ΕΝΟΡΑΣΙΣ ΑΕ Καθυστέρηση παράδοσης περιεκτικότητας. Εναλλακτι
🇬🇷 GRRIDOCA CAPS 20MG/CAP BTx5Limited availability2026-04-202026-07-31ΕΝΟΡΑΣΙΣ ΑΕ Καθυστέρηση παράδοσης περιεκτικότητας. Εναλλακτι
🇦🇹 ATTemodal 180 mg HartkapselnResolved2026-01-27

Frequently asked

Is Temozolomid currently in shortage in Europe?

Yes. As of 14 September 2026, availability issues are reported in: Greece, Sweden. Availability is national — a shortage in one country does not mean it is short everywhere.

When is the Temozolomid shortage expected to end?

Agency prognoses on file range from 2026-09-14 to 2026-09-14. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.

Are there alternatives to Temozolomid?

5 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.

Where does this Temozolomid availability data come from?

Directly from the official medicines-agency registers that list Temozolomid: BASG (Austria), EOF limited-availability list (Greece), Läkemedelsverket (Sweden). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Related medicines (same ATC class)

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Temozolomid — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/temozolomid/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Temozolomid availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/temozolomid/">Temozolomid shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>
Cite: “Temozolomid: availability status across 3 European registers — European Medicine Shortage Tracker (MobiDoctor), 14 September 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.